Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：109
作者：
Oberg, K. [1 ]
Akerstrom, G. [2 ]
Rindi, G. [3 ]
Jelic, S. [4 ]
机构：
[1] Univ Uppsala Hosp, Dept Endocrine Oncol, Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Surg, S-75185 Uppsala, Sweden
[3] UCSC Policlin A Gemelli, Inst Pathol, Rome, Italy
[4] Inst Oncol & Radiol, Internal Med Serv, Belgrade, Serbia
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
PROGNOSTIC-FACTORS; BIOTHERAPY; SURVIVAL; THERAPY; GENE;
D O I：
10.1093/annonc/mdq192
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：v223 / v227
页数：5
相关论文
共 19 条
  • [1] Surgery on neuroendocrine tumours
    Akerstrom, Goran
    Hellman, Per
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (01) : 87 - 109
  • [2] Positional cloning of the gene for multiple endocrine neoplasia-type 1
    Chandrasekharappa, SC
    Guru, SC
    Manickam, P
    Olufemi, SE
    Collins, FS
    EmmertBuck, MR
    Debelenko, LV
    Zhuang, ZP
    Lubensky, IA
    Liotta, LA
    Crabtree, JS
    Wang, YP
    Roe, BA
    Weisemann, J
    Boguski, MS
    Agarwal, SK
    Kester, MB
    Kim, YS
    Heppner, C
    Dong, QH
    Spiegel, AM
    Burns, AL
    Marx, SJ
    [J]. SCIENCE, 1997, 276 (5311) : 404 - 407
  • [3] Tumor markers in neuroendocrine tumors
    Eriksson, B
    Öberg, K
    Stridsberg, M
    [J]. DIGESTION, 2000, 62 : 33 - 38
  • [4] KLOPPEL G, 2008, NEUROENDOCRINOL 1205
  • [5] IDENTIFICATION OF THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE
    LATIF, F
    TORY, K
    GNARRA, J
    YAO, M
    DUH, FM
    ORCUTT, ML
    STACKHOUSE, T
    KUZMIN, I
    MODI, W
    GEIL, L
    SCHMIDT, L
    ZHOU, FW
    LI, H
    WEI, MH
    CHEN, F
    GLENN, G
    CHOYKE, P
    WALTHER, MM
    WENG, YK
    DUAN, DSR
    DEAN, M
    GLAVAC, D
    RICHARDS, FM
    CROSSEY, PA
    FERGUSONSMITH, MA
    LEPASLIER, D
    CHUMAKOV, I
    COHEN, D
    CHINAULT, AC
    MAHER, ER
    LINEHAN, WM
    ZBAR, B
    LERMAN, MI
    [J]. SCIENCE, 1993, 260 (5112) : 1317 - 1320
  • [6] A 5-decade analysis of 13,715 carcinoid tumors
    Modlin, IM
    Lye, KD
    Kidd, M
    [J]. CANCER, 2003, 97 (04) : 934 - 959
  • [7] Chemotherapy and biotherapy in the treatment of neuroendocrine tumours
    Öberg, K
    [J]. ANNALS OF ONCOLOGY, 2001, 12 : S111 - S114
  • [8] Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization
    Panzuto, F
    Nasoni, S
    Falconi, M
    Corleto, VD
    Capurso, G
    Cassetta, S
    Di Fonzo, M
    Tornatore, V
    Milione, M
    Angeletti, S
    Cattaruzza, MS
    Ziparo, V
    Bordi, C
    Pederzoli, P
    Delle Fave, G
    [J]. ENDOCRINE-RELATED CANCER, 2005, 12 (04) : 1083 - 1092
  • [9] Biotherapy
    Ploeckinger, U.
    Wiedenmann, B.
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (01) : 145 - 162
  • [10] TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system
    Rindi, G.
    Kloeppel, G.
    Alhman, H.
    Caplin, M.
    Couvelard, A.
    de Herder, W. W.
    Erikssson, B.
    Falchetti, A.
    Falconi, M.
    Komminoth, P.
    Koerner, M.
    Lopes, J. M.
    McNicol, A-M.
    Nilsson, O.
    Perren, A.
    Scarpa, A.
    Scoazec, J. -Y
    Wiedenmann, B.
    [J]. VIRCHOWS ARCHIV, 2006, 449 (04) : 395 - 401
12